Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biohit Oyj Board/Management Information 2018

Feb 20, 2018

3304_rns_2018-02-20_11a09a6a-add7-4997-ace7-43388d054b1a.html

Board/Management Information

Open in viewer

Opens in your device viewer

Changes to Biohit Oyj’s Management Team

Changes to Biohit Oyj’s Management Team

Biohit Oyj Company release, 20th February, 2018 at 9.30 a.m. local time (EET)

Biohit Oyj CFO Niklas Nordström is joining another company. Search for the new CFO is ongoing.

For the time being, the Chief Financial Officer's duties are managed by the CEO.

Additional information: 

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

[email protected]

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com